Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES Orgel, R., Wojdyla, D., Huberman, D., Halperin, J. L., Breithardt, G., Singer, D. E., Fox, K. A., Hankey, G. J., Mahaffey, K. W., Jones, W. S., Patel, M. R. 2017; 10 (5)

View details for DOI 10.1161/CIRCOUTCOMES.116.003520

View details for Web of Science ID 000401072100002

View details for PubMedID 28495674